# Ultragenyx Pharmaceutical Inc. (RARE) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $673M |
| 2024 | $560M |
| 2023 | $434M |
| 2022 | $363M |
| 2021 | $351M |
| 2020 | $271M |
| 2019 | $104M |
| 2018 | $51M |
| 2017 | $3M |
| 2016 | $133,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $136M |
| 2025-09-30 | $160M |
| 2025-06-30 | $166M |
| 2025-03-31 | $139M |
| 2024-09-30 | $139M |
| 2024-06-30 | $147M |
| 2024-03-31 | $109M |
| 2023-09-30 | $98M |
| 2023-06-30 | $108M |
| 2023-03-31 | $100M |
| 2022-09-30 | $91M |
| 2022-06-30 | $89M |
| 2022-03-31 | $80M |
| 2021-09-30 | $82M |
| 2021-06-30 | $87M |
| 2021-03-31 | $99M |
| 2020-09-30 | $81M |
| 2020-06-30 | $62M |
| 2020-03-31 | $36M |
| 2019-09-30 | $26M |
| 2019-06-30 | $24M |
| 2019-03-31 | $18M |
| 2018-09-30 | $12M |
| 2018-06-30 | $13M |

Source: [CompaniesByCap](https://companiesbycap.com/company/RARE/revenue)